Alan B. Lancz & Associates’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,450
Closed -$133K 178
2022
Q4
$133K Buy
+1,450
New +$117K 0.13% 184
2022
Q3
Sell
-1,450
Closed -$139K 167
2022
Q2
$139K Sell
1,450
-450
-24% -$46.6K 0.14% 165
2022
Q1
$213K Hold
1,900
0.19% 137
2021
Q4
$230K Buy
+1,900
New +$211K 0.2% 128

Other funds holding EMN

Alan B. Lancz & Associates's EMN Position: Q1 2023 in Review

Alan B. Lancz & Associates sold out of Eastman Chemical (EMN) in Q1 2023, closing a stake of 1,450 shares — an estimated $133K sold.

Alan B. Lancz & Associates first reported a position in EMN in Q4 2021 and held it in 4 quarters. The position peaked at $230K in Q4 2021. 694 funds tracked by Wall St. Rank hold EMN as of Q1 2023.

  • Alan B. Lancz & Associates reported no remaining Eastman Chemical position as of Q1 2023 after selling out during the quarter.
  • Alan B. Lancz & Associates sold 1,450 Eastman Chemical shares in Q1 2023, an estimated $133K.
  • Alan B. Lancz & Associates first reported a position in Eastman Chemical in Q4 2021 and held it in 4 quarters.
  • Alan B. Lancz & Associates's Eastman Chemical position peaked at $230K in Q4 2021.
  • 694 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2023.

Based on Alan B. Lancz & Associates's 13F filing for Q1 2023, filed 5 May 2023.